GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » EKIMAS Corp (OTCPK:ASNB) » Definitions » EV-to-EBIT

EKIMAS (EKIMAS) EV-to-EBIT : -0.81 (As of Apr. 26, 2024)


View and export this data going back to 1996. Start your Free Trial

What is EKIMAS EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, EKIMAS's Enterprise Value is $4.86 Mil. EKIMAS's EBIT for the trailing twelve months (TTM) ended in Dec. 2022 was $-5.99 Mil. Therefore, EKIMAS's EV-to-EBIT for today is -0.81.

The historical rank and industry rank for EKIMAS's EV-to-EBIT or its related term are showing as below:

ASNB's EV-to-EBIT is not ranked *
in the Diversified Financial Services industry.
Industry Median: 9.53
* Ranked among companies with meaningful EV-to-EBIT only.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. EKIMAS's Enterprise Value for the quarter that ended in Dec. 2022 was $5.63 Mil. EKIMAS's EBIT for the trailing twelve months (TTM) ended in Dec. 2022 was $-5.99 Mil. EKIMAS's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2022 was -106.34%.


EKIMAS EV-to-EBIT Historical Data

The historical data trend for EKIMAS's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EKIMAS EV-to-EBIT Chart

EKIMAS Annual Data
Trend Mar13 Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16.08 2.06 5.85 -1.80 -21.63

EKIMAS Quarterly Data
Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.47 -21.63 -1.31 -1.25 -0.94

Competitive Comparison of EKIMAS's EV-to-EBIT

For the Shell Companies subindustry, EKIMAS's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


EKIMAS's EV-to-EBIT Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, EKIMAS's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where EKIMAS's EV-to-EBIT falls into.



EKIMAS EV-to-EBIT Calculation

EKIMAS's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=4.864/-5.988
=-0.81

EKIMAS's current Enterprise Value is $4.86 Mil.
EKIMAS's EBIT for the trailing twelve months (TTM) ended in Dec. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-5.99 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


EKIMAS  (OTCPK:ASNB) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

EKIMAS's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2022 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2022 ) =EBIT / Enterprise Value (Q: Dec. 2022 )
=-5.988/5.63103125
=-106.34 %

EKIMAS's Enterprise Value for the quarter that ended in Dec. 2022 was $5.63 Mil.
EKIMAS's EBIT for the trailing twelve months (TTM) ended in Dec. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-5.99 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


EKIMAS EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of EKIMAS's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


EKIMAS (EKIMAS) Business Description

Traded in Other Exchanges
N/A
Address
3651 Lindell Road, Suite D565, Las Vegas, NV, USA, 89103
EKIMAS Corp is a shell company.
Executives
Partners Aps Gk 10 percent owner MESTERLODDEN 3B, GENTOFTE G7 2820
Henrik Oerbekker 10 percent owner 94, RUE DES AUBEPINES, L-1145, LUXEMBOURG N4 2449
Henrik Rouf 10 percent owner 468 N. CAMDEN DR., SUITE 350, BEVERLY HILLS CA 90210
Khristine L Carroll officer: EVP Commercial Operations 229 ANDOVER STREET, WILMINGTON MA 01887
Michael F Adams director, officer: Chief Executive Officer 78 E OLYMPIA AVE, C/O CARDIO TECH INTERNATIONAL INC, WOBURN MA 01810-2057
David Crispino Volpe officer: Chief Financial Officer 235 STONEBRIDGE DRIVE, NASHUA NH 03063
Michael L Barretti director 78 E OLYMPIA AVE, C/O CARDIO TECH INTERNATIONAL INC, WOBURN MA 01810-2057
Oneill William J Jr director 4000 HOLLYWOOD BLVD STE 650N, HOLLYWOOD FL 33021
Mark R Tauscher director
Eric G Walters officer: Vice President and CFO C/O MFIC CORP, 30 OSSIPEE RD., NEWTON MA 02464
Andrew Martin Reed officer: VP of Science and Technology 12106 WEST 75TH LANE, ARVADA CO 80005
Philip Alan Beck other: General manager 1230 CREEKSIDE CROSSING, STILLWATER MN 55082
Jeremiah E Dorsey director P.O. BOX 910, QUECHEE VT 05059
Leslie M Taeger officer: CFO
Douglas E Whittaker officer: President Gish Biomedical